Rolf V. Andersen

523 total citations
8 papers, 386 citations indexed

About

Rolf V. Andersen is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Rolf V. Andersen has authored 8 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Rolf V. Andersen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). Rolf V. Andersen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). Rolf V. Andersen collaborates with scholars based in Denmark. Rolf V. Andersen's co-authors include Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Henrik Birgens, Hans H. Wittrup, Peter Schnohr, Rolf Steffensen, Gorm Boje Jensen, Henrik Sillesen, Pia R. Kamstrup and Trine Holm Johannsen and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Rolf V. Andersen

8 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf V. Andersen Denmark 6 149 136 122 117 104 8 386
Terrence Tan Australia 8 124 0.8× 100 0.7× 20 0.2× 63 0.5× 51 0.5× 10 355
Lilian McGregor France 11 30 0.2× 175 1.3× 68 0.6× 19 0.2× 39 0.4× 15 367
Olaf Herkert Germany 7 71 0.5× 82 0.6× 22 0.2× 28 0.2× 12 0.1× 7 365
Katayoun Pourvali Iran 11 49 0.3× 76 0.6× 20 0.2× 48 0.4× 53 0.5× 27 309
Bomee Chung Germany 12 21 0.1× 399 2.9× 35 0.3× 272 2.3× 188 1.8× 14 585
Ylva Bonde Sweden 7 115 0.8× 50 0.4× 112 0.9× 23 0.2× 32 0.3× 7 359
Erin Morgan United States 8 129 0.9× 21 0.2× 75 0.6× 27 0.2× 16 0.2× 18 341
In-Uk Koh South Korea 11 38 0.3× 29 0.2× 36 0.3× 16 0.1× 59 0.6× 14 339
Aaron Chapla India 11 107 0.7× 67 0.5× 151 1.2× 40 0.3× 19 0.2× 35 362
H.A.M. Töns Netherlands 7 186 1.2× 54 0.4× 129 1.1× 6 0.1× 11 0.1× 13 417

Countries citing papers authored by Rolf V. Andersen

Since Specialization
Citations

This map shows the geographic impact of Rolf V. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf V. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf V. Andersen more than expected).

Fields of papers citing papers by Rolf V. Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf V. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf V. Andersen. The network helps show where Rolf V. Andersen may publish in the future.

Co-authorship network of co-authors of Rolf V. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf V. Andersen. A scholar is included among the top collaborators of Rolf V. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf V. Andersen. Rolf V. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Johannsen, Trine Holm, Pia R. Kamstrup, Rolf V. Andersen, et al.. (2008). Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease. The Journal of Clinical Endocrinology & Metabolism. 94(4). 1264–1273. 73 indexed citations
3.
Kannangara, C. Gamini, Rolf V. Andersen, Bo Pontoppidan, Robert D. Willows, & Diter von Wettstein. (2007). Enzymic and Mechanistic Studies on the Conversion of Glutamate to 5‐Aminolaevulinate. Novartis Foundation symposium. 180. 3–25. 5 indexed citations
5.
Sethi, Amar A, Anne Tybjærg‐Hansen, Rolf V. Andersen, & Børge G. Nordestgaard. (2004). Nanogen Microelectronic Chip for Large-Scale Genotyping. Clinical Chemistry. 50(2). 443–446. 23 indexed citations
6.
Andersen, Rolf V., Hans H. Wittrup, Anne Tybjærg‐Hansen, et al.. (2003). Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease. Journal of the American College of Cardiology. 41(11). 1972–1982. 104 indexed citations
7.
Andersen, Rolf V., et al.. (2003). Hemochromatosis mutations in the general population: iron overload progression rate. Blood. 103(8). 2914–2919. 143 indexed citations
8.
Andersen, Rolf V., Hans H. Wittrup, Anne Tybjærg‐Hansen, et al.. (2001). Hepatic lipase promoter SNPs associated with increased HDL cholesterol and paradoxically an increased risk of ischemic heart disease; the Copenhagen City Heart Study. Atherosclerosis Supplements. 2(2). 44–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026